First Trust Nasdaq Pharmaceuticals (FTXH)
NASDAQ
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 0.706 | 0.83 | 1.735 | -5.433 | 29.59 | 5.579 | -0.624 | 6.861 |
Return on Equity (%) | 0.706 | 0.83 | 1.736 | -5.435 | 29.603 | 5.581 | -0.625 | 6.865 |
Return on Invested Capital (%) | 700 | 1133.333 | 2800 | 620 | 800 | 826.667 | 1603.226 | 1480 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 13.213 | 21.14 | 21.504 | 19.367 | 25.511 | 26.632 | 26.112 | 27.996 |
Earnings Per Share | 0.047 | 0.17 | 0.26 | -1.013 | 4.923 | 1.565 | -0.125 | 2.455 |
Cash Per Share | 0.013 | 0.01 | N/A | 0.003 | 0.011 | 0.002 | 0.024 | N/A |
Working Capital Per Share | 0.013 | 0.01 | 0.004 | 0.063 | 0.032 | 0.032 | 0.033 | 0.005 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | 0.093 | 0.68 | 0.364 | -0.8 | 5.137 | 1.835 | 0.275 | 2.869 |
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 150k | 100k | 250k | 300k | 750k | 650k | 1,25M | 750k |
Fin d'année 31 Mars 2024 | ||||||||
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 20,54M |
Ratio cours/bénéfice | 11,11 |
Ratio prix/ventes | 42,97 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 0,97 |
Rendement de dividende | 139,53% |
Actions en circulation | 750k |
Volume moyen (1 semaine) | 933 |
Volume moyen (1 mois) | 1,43k |
Variation sur 52 semaines | 2,77% |
Plus haut sur 52 semaines | 29,72 |
Plus bas sur 52 semaines | 25,73 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales